Patients should be advised to ensure adequate oral moisture before placing the tablet under the tongue, and artificial saliva products may be helpful in cases of severe xerostomia
Nature 610 , 775782 (2022)
sequential administration such as administration of an oral form of a PDE-5 inhibitor, followed by administration of an intranasal form of a melanocortin agonist, preferably wherein the administration of the intranasal form of a melanocortin agonist is a determined time interval subsequent to oral administration of a PDE-5 inhibitor, optimal therapeutic results may be obtained with minimal adverse side effects
Tissues were obtained at days 1, 3, 5, 8, 12, 18, and 22 after depilation (three mice per time point), encompassing hair development from early anagen to telogen